The food lists designed for GLP-1 users prioritize easily digestible, protein-rich options that work well even when nothing sounds appetizing
Neurogastroenterol Motil 21(7):706e38 Parker VER, Robertson D, Wang T, Hornigold DC, Petrone M, Cooper AT et al (2019) Efficacy, safety, and mechanistic insights of cotadutide a dual receptor glucagon-like peptide-1 and glucagon agonist
GLP-1 agonists are often slowly increased over time to minimize side effects
Obesity is associated with an increased risk of at least thirteen cancers and with negative cancer outcomes including increased metastasis, impaired response to therapy, elevated risk of recurrence, and an increase in cancer-related mortality 2,3,4,5
Start your intake How GLP-1 Alternatives Differ in Mechanism and Clinical Action Semaglutide (Ozempic, Wegovy) activates GLP-1 receptors to increase insulin secretion, slow gastric emptying, and reduce appetite
[Read More] Kozina LS, Arutjunyan AV, Khavinson VKh